{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T12:03:34Z","timestamp":1795089814380,"version":"4.10.2"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2022,8,29]],"date-time":"2022-08-29T00:00:00Z","timestamp":1661731200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,8,29]],"date-time":"2022-08-29T00:00:00Z","timestamp":1661731200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000050","name":"U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["HL 7954-20"],"award-info":[{"award-number":["HL 7954-20"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["HL142186"],"award-info":[{"award-number":["HL142186"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["GM132261"],"award-info":[{"award-number":["GM132261"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["HL089847"],"award-info":[{"award-number":["HL089847"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["HL105993"],"award-info":[{"award-number":["HL105993"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["AG17022"],"award-info":[{"award-number":["AG17022"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["HL152446"],"award-info":[{"award-number":["HL152446"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012643","name":"Edward Mallinckrodt, Jr. Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012643","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011643","name":"Blavatnik Family Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011643","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["DK019525"],"award-info":[{"award-number":["DK019525"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001149","name":"George Gund Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001149","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","award":["W81XWH18-1-0503"],"award-info":[{"award-number":["W81XWH18-1-0503"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Cardiovasc Res"],"DOI":"10.1038\/s44161-022-00117-6","type":"journal-article","created":{"date-parts":[[2022,8,29]],"date-time":"2022-08-29T12:04:01Z","timestamp":1661774641000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":51,"title":["Integrated landscape of cardiac metabolism in end-stage human nonischemic dilated cardiomyopathy"],"prefix":"10.1038","author":[{"given":"Emily","family":"Flam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6651-4213","authenticated-orcid":false,"given":"Cholsoon","family":"Jang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle","family":"Murashige","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael P.","family":"Morley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunhee","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel S.","family":"Kantner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"Pepper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr","given":"Kenneth C.","family":"Bedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeff","family":"Brandimarto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3696-9131","authenticated-orcid":false,"given":"Benjamin L.","family":"Prosser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Cappola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathaniel W.","family":"Snyder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua D.","family":"Rabinowitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth B.","family":"Margulies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1368-2453","authenticated-orcid":false,"given":"Zolt","family":"Arany","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,8,29]]},"reference":[{"key":"117_CR1","doi-asserted-by":"publisher","unstructured":"Benjamin, E. J. et al. Heart Disease and Stroke Statistics. 2019 update: a report from the American Heart Association. Circulation https:\/\/doi.org\/10.1161\/CIR.0000000000000659 (2019).","DOI":"10.1161\/CIR.0000000000000659"},{"key":"117_CR2","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.1016\/j.jacc.2017.08.074","volume":"70","author":"KS Shah","year":"2017","unstructured":"Shah, K. S. et al. Heart failure with preserved, borderline, and reduced ejection fraction: 5-year outcomes. J. Am. Coll. Cardiol. 70, 2476\u20132486 (2017).","journal-title":"J. Am. Coll. Cardiol."},{"key":"117_CR3","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1002\/ejhf.1594","volume":"21","author":"NR Jones","year":"2019","unstructured":"Jones, N. R., Roalfe, A. K., Adoki, I., Hobbs, F. D. R. & Taylor, C. J. Survival of patients with chronic heart failure in the community: a systematic review and meta-analysis. Eur. J. Heart Fail. 21, 1306\u20131325 (2019).","journal-title":"Eur. J. Heart Fail."},{"key":"117_CR4","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1161\/01.RES.0000137170.41939.d9","volume":"95","author":"JS Ingwall","year":"2004","unstructured":"Ingwall, J. S. & Weiss, R. G. Is the failing heart energy starved? On using chemical energy to support cardiac function. Circ. Res. 95, 135\u2013145 (2004).","journal-title":"Circ. Res."},{"key":"117_CR5","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1056\/NEJMra063052","volume":"356","author":"S Neubauer","year":"2007","unstructured":"Neubauer, S. The failing heart\u2014an engine out of fuel. N. Engl. J. Med. 356, 1140\u20131151 (2007).","journal-title":"N. Engl. J. Med."},{"key":"117_CR6","doi-asserted-by":"crossref","first-page":"e003190","DOI":"10.1161\/JAHA.115.003190","volume":"5","author":"WG Hunter","year":"2016","unstructured":"Hunter, W. G. et al. Metabolomic profiling identifies novel circulating biomarkers of mitochondrial dysfunction differentially elevated in heart failure with preserved versus reduced ejection fraction: evidence for shared metabolic impairments in clinical heart failure. J. Am. Heart Assoc. 5, e003190 (2016).","journal-title":"J. Am. Heart Assoc."},{"key":"117_CR7","doi-asserted-by":"crossref","first-page":"H768","DOI":"10.1152\/ajpheart.00820.2016","volume":"313","author":"M Ruiz","year":"2017","unstructured":"Ruiz, M. et al. Circulating acylcarnitine profile in human heart failure: a surrogate of fatty acid metabolic dysregulation in mitochondria and beyond. Am. J. Physiol. Heart. Circ. Physiol. 313, H768\u2013H781 (2017).","journal-title":"Am. J. Physiol. Heart. Circ. Physiol."},{"key":"117_CR8","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1126\/science.abc8861","volume":"370","author":"D Murashige","year":"2020","unstructured":"Murashige, D. et al. Comprehensive quantification of fuel use by the failing and nonfailing human heart. Science 370, 364\u2013368 (2020).","journal-title":"Science"},{"key":"117_CR9","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.jacbts.2016.06.009","volume":"1","author":"NA Diakos","year":"2016","unstructured":"Diakos, N. A. et al. Evidence of glycolysis up-regulation and pyruvate mitochondrial oxidation mismatch during mechanical unloading of the failing human heart: implications for cardiac reloading and conditioning. JACC Basic Transl. Sci. 1, 432\u2013444 (2016).","journal-title":"JACC Basic Transl. Sci."},{"key":"117_CR10","doi-asserted-by":"crossref","first-page":"2844","DOI":"10.1161\/CIRCULATIONAHA.111.060889","volume":"125","author":"A Chokshi","year":"2012","unstructured":"Chokshi, A. et al. Ventricular assist device implantation corrects myocardial lipotoxicity, reverses insulin resistance, and normalizes cardiac metabolism in patients with advanced heart failure. Circulation 125, 2844\u20132853 (2012).","journal-title":"Circulation"},{"key":"117_CR11","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1161\/CIRCGENETICS.113.000404","volume":"7","author":"AA Gupte","year":"2014","unstructured":"Gupte, A. A. et al. Mechanical unloading promotes myocardial energy recovery in human heart failure. Circ. Cardiovasc. Genet. 7, 266\u2013276 (2014).","journal-title":"Circ. Cardiovasc. Genet."},{"key":"117_CR12","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1038\/s41591-018-0046-2","volume":"24","author":"CY Chen","year":"2018","unstructured":"Chen, C. Y. et al. Suppression of detyrosinated microtubules improves cardiomyocyte function in human heart failure. Nat. Med. 24, 1225\u20131233 (2018).","journal-title":"Nat. Med."},{"key":"117_CR13","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1186\/s12864-018-5213-9","volume":"19","author":"ME Sweet","year":"2018","unstructured":"Sweet, M. E. et al. Transcriptome analysis of human heart failure reveals dysregulated cell adhesion in dilated cardiomyopathy and activated immune pathways in ischemic heart failure. BMC Genom. 19, 812 (2018).","journal-title":"BMC Genom."},{"key":"117_CR14","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.7326\/0003-4819-12-8-1233","volume":"12","author":"G Herrmann","year":"1939","unstructured":"Herrmann, G. & Decherd, G. M. The chemical nature of heart failure. Ann. Intern. Med. 12, 1233\u20131244 (1939).","journal-title":"Ann. Intern. Med."},{"key":"117_CR15","doi-asserted-by":"publisher","unstructured":"Ingwall, J. S. ATP and the Heart (Springer New York, 2002). https:\/\/doi.org\/10.1007\/978-1-4615-1093-2","DOI":"10.1007\/978-1-4615-1093-2"},{"key":"117_CR16","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1161\/01.CIR.96.7.2190","volume":"96","author":"S Neubauer","year":"1997","unstructured":"Neubauer, S. et al. Myocardial phosphocreatine-to-ATP ratio is a predictor of mortality in patients with dilated cardiomyopathy. Circulation 96, 2190\u20132196 (1997).","journal-title":"Circulation"},{"key":"117_CR17","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/S0735-1097(02)02160-5","volume":"40","author":"M Beer","year":"2002","unstructured":"Beer, M. et al. Absolute concentrations of high-energy phosphate metabolites in normal, hypertrophied, and failing human myocardium measured noninvasively with 31P-SLOOP magnetic resonance spectroscopy. J. Am. Coll. Cardiol. 40, 1267\u20131274 (2002).","journal-title":"J. Am. Coll. Cardiol."},{"key":"117_CR18","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1161\/01.CIR.100.20.2113","volume":"100","author":"W Shen","year":"1999","unstructured":"Shen, W. et al. Progressive loss of myocardial ATP due to a loss of total purines during the development of heart failure in dogs: a compensatory role for the parallel loss of creatine. Circulation 100, 2113\u20132118 (1999).","journal-title":"Circulation"},{"key":"117_CR19","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1161\/CIRCULATIONAHA.115.017545","volume":"133","author":"KC Bedi","year":"2016","unstructured":"Bedi, K. C. et al. Evidence for intramyocardial disruption of lipid metabolism and increased myocardial ketone utilization in advanced human heart failure. Circulation 133, 706\u2013716 (2016).","journal-title":"Circulation"},{"key":"117_CR20","doi-asserted-by":"crossref","first-page":"2765","DOI":"10.1161\/CIRCULATIONAHA.119.039610","volume":"139","author":"JR Goldenberg","year":"2019","unstructured":"Goldenberg, J. R. et al. Preservation of acyl coenzyme a attenuates pathological and metabolic cardiac remodeling through selective lipid trafficking. Circulation 139, 2765\u20132777 (2019).","journal-title":"Circulation"},{"key":"117_CR21","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1172\/JCI10947","volume":"107","author":"HC Chiu","year":"2001","unstructured":"Chiu, H. C. et al. A novel mouse model of lipotoxic cardiomyopathy. J. Clin. Invest. 107, 813\u2013822 (2001).","journal-title":"J. Clin. Invest."},{"key":"117_CR22","doi-asserted-by":"crossref","first-page":"e008293","DOI":"10.1161\/JAHA.117.008293","volume":"7","author":"F Pascual","year":"2018","unstructured":"Pascual, F., Schisler, J. C., Grevengoed, T. J., Willis, M. S. & Coleman, R. A. Modeling the transition from decompensated to pathological hypertrophy. J. Am. Heart Assoc. 7, e008293 (2018).","journal-title":"J. Am. Heart Assoc."},{"key":"117_CR23","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1128\/MCB.01085-10","volume":"31","author":"JM Ellis","year":"2011","unstructured":"Ellis, J. M. et al. Mouse cardiac acyl coenzyme a synthetase 1 deficiency impairs fatty acid oxidation and induces cardiac hypertrophy. Mol. Cell. Biol. 31, 1252\u20131262 (2011).","journal-title":"Mol. Cell. Biol."},{"key":"117_CR24","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1161\/CIRCRESAHA.113.300376","volume":"113","author":"T Doenst","year":"2013","unstructured":"Doenst, T., Nguyen, T. D. & Abel, E. D. Cardiac metabolism in heart failure: implications beyond ATP production. Circ. Res. 113, 709\u2013724 (2013).","journal-title":"Circ. Res."},{"key":"117_CR25","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1161\/CIRCRESAHA.121.318241","volume":"128","author":"GD Lopaschuk","year":"2021","unstructured":"Lopaschuk, G. D., Karwi, Q. G., Tian, R., Wende, A. R. & Abel, E. D. Cardiac energy metabolism in heart failure. Circ. Res. 128, 1487\u20131513 (2021).","journal-title":"Circ. Res."},{"key":"117_CR26","doi-asserted-by":"crossref","first-page":"2923","DOI":"10.1161\/hc4901.100526","volume":"104","author":"P Razeghi","year":"2001","unstructured":"Razeghi, P. et al. Metabolic gene expression in fetal and failing human heart. Circulation 104, 2923\u20132931 (2001).","journal-title":"Circulation"},{"key":"117_CR27","doi-asserted-by":"crossref","first-page":"e17674","DOI":"10.1371\/journal.pone.0017674","volume":"6","author":"S John","year":"2011","unstructured":"John, S., Weiss, J. N. & Ribalet, B. Subcellular localization of hexokinases I and II directs the metabolic fate of glucose. PLoS ONE 6, e17674 (2011).","journal-title":"PLoS ONE"},{"key":"117_CR28","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/j.molcel.2022.02.028","volume":"82","author":"AD Jesus","year":"2022","unstructured":"Jesus, A. D. et al. Hexokinase 1 cellular localization regulates the metabolic fate of glucose. Mol. Cell 82, 1261\u20131277.e9 (2022).","journal-title":"Mol. Cell"},{"key":"117_CR29","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1161\/01.CIR.0000034049.61181.F3","volume":"106","author":"R Liao","year":"2002","unstructured":"Liao, R. et al. Cardiac-specific overexpression of GLUT1 prevents the development of heart failure attributable to pressure overload in mice. Circulation 106, 2125\u20132131 (2002).","journal-title":"Circulation"},{"key":"117_CR30","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1161\/CIRCULATIONAHA.105.534594","volume":"112","author":"I Luptak","year":"2005","unstructured":"Luptak, I. et al. Decreased contractile and metabolic reserve in peroxisome proliferator-activated receptor-alpha-null hearts can be rescued by increasing glucose transport and utilization. Circulation 112, 2339\u20132346 (2005).","journal-title":"Circulation"},{"key":"117_CR31","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.cmet.2016.11.005","volume":"25","author":"T Li","year":"2017","unstructured":"Li, T. et al. Defective branched-chain amino acid catabolism disrupts glucose metabolism and sensitizes the heart to ischemia\u2013reperfusion injury. Cell Metab. 25, 374\u2013385 (2017).","journal-title":"Cell Metab."},{"key":"117_CR32","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1038\/s42255-020-00296-1","volume":"2","author":"KS McCommis","year":"2020","unstructured":"McCommis, K. S. et al. Nutritional modulation of heart failure in mitochondrial pyruvate carrier-deficient mice. Nat. Metab. 2, 1232\u20131247 (2020).","journal-title":"Nat. Metab."},{"key":"117_CR33","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1074\/mcp.M115.051862","volume":"15","author":"M Fern\u00e1ndez-Caggiano","year":"2016","unstructured":"Fern\u00e1ndez-Caggiano, M. et al. Analysis of mitochondrial proteins in the surviving myocardium after ischemia identifies mitochondrial pyruvate carrier expression as possible mediator of tissue viability. Mol. Cell. Proteom. 15, 246\u2013255 (2016).","journal-title":"Mol. Cell. Proteom."},{"key":"117_CR34","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1093\/oxfordjournals.eurheartj.a059743","volume":"11","author":"A Buchwald","year":"1990","unstructured":"Buchwald, A. et al. Alterations of the mitochondrial respiratory chain in human dilated cardiomyopathy. Eur. Heart J 11, 509\u2013516 (1990).","journal-title":"Eur. Heart J"},{"key":"117_CR35","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1161\/CIRCRESAHA.109.212753","volume":"106","author":"G Karamanlidis","year":"2010","unstructured":"Karamanlidis, G. et al. Defective DNA replication impairs mitochondrial biogenesis in human failing hearts. Circ. Res. 106, 1541\u20131548 (2010).","journal-title":"Circ. Res."},{"key":"117_CR36","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/S0008-6363(99)00388-0","volume":"45","author":"D Jarreta","year":"2000","unstructured":"Jarreta, D. et al. Mitochondrial function in heart muscle from patients with idiopathic dilated cardiomyopathy. Cardiovasc. Res. 45, 860\u2013865 (2000).","journal-title":"Cardiovasc. Res."},{"key":"117_CR37","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.yjmcc.2012.11.008","volume":"55","author":"B Lauzier","year":"2013","unstructured":"Lauzier, B. et al. Metabolic effects of glutamine on the heart: anaplerosis versus the hexosamine biosynthetic pathway. J. Mol. Cell. Cardiol. 55, 92\u2013100 (2013).","journal-title":"J. Mol. Cell. Cardiol."},{"key":"117_CR38","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1002\/nbm.1569","volume":"24","author":"W Li","year":"2011","unstructured":"Li, W. et al. Delineation of substrate selection and anaplerosis in tricarboxylic acid cycle of the heart by 13C NMR spectroscopy and mass spectrometry. NMR Biomed. 24, 176\u2013187 (2011).","journal-title":"NMR Biomed."},{"key":"117_CR39","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.abb.2007.02.022","volume":"463","author":"T Kasumov","year":"2007","unstructured":"Kasumov, T. et al. Mass isotopomer study of anaplerosis from propionate in the perfused rat heart. Arch. Biochem. Biophys. 463, 110\u2013117 (2007).","journal-title":"Arch. Biochem. Biophys."},{"key":"117_CR40","doi-asserted-by":"crossref","first-page":"E351","DOI":"10.1152\/ajpendo.00354.2002","volume":"284","author":"WZ Martini","year":"2003","unstructured":"Martini, W. Z. et al. Quantitative assessment of anaplerosis from propionate in pig heart in vivo. Am. J. Physiol. Endocrinol. Metab. 284, E351\u2013E356 (2003).","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"117_CR41","doi-asserted-by":"crossref","first-page":"H2390","DOI":"10.1152\/ajpheart.2000.279.5.H2390","volume":"279","author":"AR Panchal","year":"2000","unstructured":"Panchal, A. R. et al. Partitioning of pyruvate between oxidation and anaplerosis in swine hearts. Am. J. Physiol. Heart. Circ. Physiol. 279, H2390\u2013H2398 (2000).","journal-title":"Am. J. Physiol. Heart. Circ. Physiol."},{"key":"117_CR42","doi-asserted-by":"crossref","first-page":"26125","DOI":"10.1074\/jbc.272.42.26125","volume":"272","author":"C B","year":"1997","unstructured":"B, C. et al. A 13C mass isotopomer study of anaplerotic pyruvate carboxylation in perfused rat hearts. J. Biol. Chem. 272, 26125\u201326131 (1997).","journal-title":"J. Biol. Chem."},{"key":"117_CR43","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1161\/CIRCRESAHA.118.312660","volume":"122","author":"R Lahey","year":"2018","unstructured":"Lahey, R. et al. Enhanced redox state and efficiency of glucose oxidation with miR based suppression of maladaptive NADPH-dependent malic enzyme 1 expression in hypertrophied hearts. Circ. Res. 122, 836\u2013845 (2018).","journal-title":"Circ. Res."},{"key":"117_CR44","doi-asserted-by":"crossref","first-page":"e124079","DOI":"10.1172\/jci.insight.124079","volume":"4","author":"JL Horton","year":"2019","unstructured":"Horton, J. L. et al. The failing heart utilizes 3-hydroxybutyrate as a metabolic stress defense. JCI Insight 4, e124079 (2019).","journal-title":"JCI Insight"},{"key":"117_CR45","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1161\/CIRCULATIONAHA.115.017355","volume":"133","author":"G Aubert","year":"2016","unstructured":"Aubert, G. et al. The failing heart relies on ketone bodies as a fuel. Circulation 133, 698\u2013705 (2016).","journal-title":"Circulation"},{"key":"117_CR46","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1161\/CIRCULATIONAHA.120.052671","volume":"143","author":"AN Carley","year":"2021","unstructured":"Carley, A. N. et al. Short-chain fatty acids outpace ketone oxidation in the failing heart. Circulation 143, 1797\u20131808 (2021).","journal-title":"Circulation"},{"key":"117_CR47","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/s42255-021-00517-1","volume":"4","author":"X Li","year":"2022","unstructured":"Li, X. et al. Circulating metabolite homeostasis achieved through mass action. Nat. Metab. 4, 141\u2013152 (2022).","journal-title":"Nat. Metab."},{"key":"117_CR48","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/s12933-019-0892-3","volume":"18","author":"GM Uddin","year":"2019","unstructured":"Uddin, G. M. et al. Impaired branched chain amino acid oxidation contributes to cardiac insulin resistance in heart failure. Cardiovasc. Diabetol. 18, 86 (2019).","journal-title":"Cardiovasc. Diabetol."},{"key":"117_CR49","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1161\/CIRCULATIONAHA.115.020226","volume":"133","author":"H Sun","year":"2016","unstructured":"Sun, H. et al. Catabolic defect of branched-chain amino acids promotes heart failure. Circulation 133, 2038\u20132049 (2016).","journal-title":"Circulation"},{"key":"117_CR50","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1146\/annurev-physiol-020518-114455","volume":"81","author":"M Neinast","year":"2019","unstructured":"Neinast, M., Murashige, D. & Arany, Z. Branched chain amino acids. Annu. Rev. Physiol. 81, 139\u2013164 (2019).","journal-title":"Annu. Rev. Physiol."},{"key":"117_CR51","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s10545-013-9669-0","volume":"37","author":"B Su","year":"2014","unstructured":"Su, B. & Ryan, R. O. Metabolic biology of 3-methylglutaconic acid-uria: a new perspective. J. Inherit. Metab. Dis. 37, 359\u2013368 (2014).","journal-title":"J. Inherit. Metab. Dis."},{"key":"117_CR52","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.phrs.2017.12.018","volume":"130","author":"L Fan","year":"2018","unstructured":"Fan, L., Hsieh, P. N., Sweet, D. R. & Jain, M. K. Kr\u00fcppel-like factor 15: regulator of BCAA metabolism and circadian protein rhythmicity. Pharmacol. Res. 130, 123\u2013126 (2018).","journal-title":"Pharmacol. Res."},{"key":"117_CR53","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.tem.2015.07.006","volume":"26","author":"B Chaurasia","year":"2015","unstructured":"Chaurasia, B. & Summers, S. A. Ceramides\u2014lipotoxic inducers of metabolic disorders. Trends Endocrinol. Metab. 26, 538\u2013550 (2015).","journal-title":"Trends Endocrinol. Metab."},{"key":"117_CR54","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/s41569-021-00536-1","volume":"18","author":"RH Choi","year":"2021","unstructured":"Choi, R. H., Tatum, S. M., Symons, J. D., Summers, S. A. & Holland, W. L. Ceramides and other sphingolipids as drivers of cardiovascular disease. Nat. Rev. Cardiol. 18, 701\u2013711 (2021).","journal-title":"Nat. Rev. Cardiol."},{"key":"117_CR55","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.cjca.2014.12.007","volume":"31","author":"J Yu","year":"2015","unstructured":"Yu, J. et al. Ceramide is upregulated and associated with mortality in patients with chronic heart failure. Can. J. Cardiol. 31, 357\u2013363 (2015).","journal-title":"Can. J. Cardiol."},{"key":"117_CR56","doi-asserted-by":"publisher","unstructured":"Yin, W. et al. Plasma ceramides and cardiovascular events in hypertensive patients at high cardiovascular risk. Am. J. Hypertens. https:\/\/doi.org\/10.1093\/ajh\/hpab105 (2021).","DOI":"10.1093\/ajh\/hpab105"},{"key":"117_CR57","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1161\/CIRCRESAHA.120.317883","volume":"128","author":"C Wittenbecher","year":"2021","unstructured":"Wittenbecher, C. et al. Lipid profiles and heart failure risk: results from two prospective studies. Circ. Res. 128, 309\u2013320 (2021).","journal-title":"Circ. Res."},{"key":"117_CR58","doi-asserted-by":"crossref","first-page":"82922","DOI":"10.1172\/jci.insight.82922","volume":"2","author":"R Ji","year":"2017","unstructured":"Ji, R. et al. Increased de novo ceramide synthesis and accumulation in failing myocardium. JCI Insight 2, 82922 (2017).","journal-title":"JCI Insight"},{"key":"117_CR59","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/S1388-1981(02)00174-9","volume":"1582","author":"JS Karliner","year":"2002","unstructured":"Karliner, J. S. Lysophospholipids and the cardiovascular system. Biochim. Biophys. Acta Mol. Cell Biol. Lipids 1582, 216\u2013221 (2002).","journal-title":"Biochim. Biophys. Acta Mol. Cell Biol. Lipids"},{"key":"117_CR60","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.3390\/ijms20051149","volume":"20","author":"S-H Law","year":"2019","unstructured":"Law, S.-H. et al. An updated review of lysophosphatidylcholine metabolism in human diseases. Int. J. Mol. Sci. 20, 1149 (2019).","journal-title":"Int. J. Mol. Sci."},{"key":"117_CR61","doi-asserted-by":"crossref","first-page":"3651","DOI":"10.1007\/s00216-016-9448-5","volume":"408","author":"AJ Frey","year":"2016","unstructured":"Frey, A. J. et al. LC-quadrupole\/Orbitrap high-resolution mass spectrometry enables stable isotope-resolved simultaneous quantification and 13C-isotopic labeling of acyl-coenzyme A thioesters. Anal. Bioanal. Chem. 408, 3651\u20133658 (2016).","journal-title":"Anal. Bioanal. Chem."},{"key":"117_CR62","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.ab.2014.12.014","volume":"474","author":"NW Snyder","year":"2015","unstructured":"Snyder, N. W. et al. Production of stable isotope-labeled acyl-coenzyme A thioesters by yeast stable isotope labeling by essential nutrients in cell culture. Anal. Biochem. 474, 59\u201365 (2015).","journal-title":"Anal. Biochem."},{"key":"117_CR63","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.mex.2017.09.007","volume":"4","author":"C Zhu","year":"2017","unstructured":"Zhu, C. & Guo, W. Detection and quantification of the giant protein titin by SDS-agarose gel electrophoresis. MethodsX 4, 320\u2013327 (2017).","journal-title":"MethodsX"}],"container-title":["Nature Cardiovascular Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s44161-022-00117-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s44161-022-00117-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s44161-022-00117-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,5]],"date-time":"2022-10-05T08:59:41Z","timestamp":1664960381000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s44161-022-00117-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,29]]},"references-count":63,"alternative-id":["117"],"URL":"https:\/\/doi.org\/10.1038\/s44161-022-00117-6","relation":{},"ISSN":["2731-0590"],"issn-type":[{"value":"2731-0590","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,29]]},"assertion":[{"value":"6 August 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}